Agilent Technologies (A) Debt to Equity (2006 - 2026)
Agilent Technologies (A) debt to equity from Oct 31, 2006 to Apr 30, 2026. The current Agilent Technologies (A) debt to equity is 47.11%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Agilent Technologies (A)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 49.76% | -13.43% |
| 2024 | 57.48% | +22.83% |
| 2023 | 46.79% | -10.35% |
| 2022 | 52.20% | +3.07% |
| 2021 | 50.64% | +4.61% |
| 2020 | 48.41% | -4.51% |
| 2019 | 50.70% | +29.43% |
| 2018 | 39.17% | -0.57% |
| 2018 | 39.39% | -5.37% |
| 2017 | 41.63% | -7.24% |
| 2016 | 44.87% | +12.98% |
| 2015 | 39.72% | +26.60% |
| 2014 | 31.37% | -38.56% |
| 2013 | 51.06% | +12.02% |
| 2012 | 45.58% | -10.13% |
| 2011 | 50.72% | -55.64% |
| 2010 | 114.34% | -1.36% |
| 2009 | 115.92% | +95.93% |
| 2008 | 59.16% | N/A |
| 2007 | 0.00% | N/A |
| 2006 | 0.00% | N/A |
Comparison Agilent Technologies (A) debt to equity with competitors
Agilent Technologies (A) debt to equity is 47.11%.
| Ticker | Name | Debt to Equity | Upside |
|---|---|---|---|
| CRL | Charles River Laboratories International Inc | 0.23% | -99.52% |
| OPK | Opko Health Inc | 0.29% | -99.38% |
| PRPO | Precipio Inc | 0.49% | -98.95% |
| CSTL | Castle Biosciences Inc | 2.18% | -95.37% |
| NTRA | Natera Inc | 4.53% | -90.39% |
| APDN | Applied Dna Sciences Inc | 4.60% | -90.24% |
| DGX | Quest Diagnostics Inc | 6.83% | -85.50% |
| PRPH | ProPhase Labs Inc | 7.54% | -84.00% |
| BLLN | Billiontoone Inc - Class A | 17.80% | -62.21% |
| IDXX | Idexx Laboratories Inc | 28.91% | -38.63% |
| ICLR | Icon Plc | 31.25% | -33.67% |
| WAT | Waters Corp | 31.75% | -32.60% |
| DHR | Danaher Corp | 34.91% | -25.89% |
| MYGN | Myriad Genetics Inc | 35.66% | -24.31% |
| WGS | GeneDx Holdings Corp - Class A | 38.06% | -19.20% |
| NEO | Neogenomics Inc | 40.86% | -13.25% |
| QGEN | Qiagen NV | 43.79% | -7.04% |
| RVTY | Revvity Inc | 44.66% | -5.19% |
| ADPT | Adaptive Biotechnologies Corp | 60.35% | +28.10% |
| LH | Laboratory Corp Of America Holdings | 72.57% | +54.05% |
| TMO | Thermo Fisher Scientific Inc | 88.65% | +88.18% |
| RDNT | Radnet Inc | 100.55% | +113.45% |
| XGN | Exagen Inc | 158.47% | +236.41% |
| IQV | IQVIA Holdings Inc | 254.51% | +440.27% |
| SHC | Sotera Health Company | 343.50% | +629.18% |
| NOTV | Inotiv, Inc. Common Stock | 532.33% | +1030.03% |
| BDSX | Biodesix Inc | 547.55% | +1062.33% |